查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372865

诊断影像市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品类型、按应用、最终用户、地区和竞争细分

Diagnostic Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年，全球诊断影像市场估值达250.9亿美元，预计在预测期内将显着成长，预计到2028年复合年增长率(CAGR)为5.53%。

诊断影像包括多种用于视觉化人体的技术，是诊断、监测和治疗医疗状况的重要工具。每种影像方式都能提供对目标身体部位的独特见解，包括疾病、损伤的检测或医疗介入有效性的评估。这些用于捕捉体内结构的非侵入性方法统称为诊断影像，涵盖 X 光、磁振造影 (MRI)、电脑断层扫描 (CT)、产前诊断和其他专门模式等技术。

医疗保健专业人员利用诊断影像的力量来建立精确的诊断并进行全面的患者评估。此外，这项技术在密切监测患者对治疗方案和药物的反应方面发挥着至关重要的作用。诊断影像涵盖广泛的程序，使医疗保健提供者能够获得对身体内部结构的宝贵视觉洞察，最终有助于准确识别健康问题或伤害的根本原因。

市场概况
预测期 2024-2028
2022 年市场规模 250.9亿美元
2028 年市场规模 349亿美元
2023-2028 年复合年增长率 5.53%
成长最快的细分市场 肿瘤学
最大的市场 北美洲

主要市场驱动因素

慢性病盛行率上升

慢性病盛行率的上升预计将显着增加未来对诊断影像的需求。这种上升趋势是由几个相互关联的因素推动的，这些因素强调了影像技术在慢性健康状况的诊断和管理中的关键作用。

更多采用诊断成像中的先进技术

诊断影像中先进技术的日益采用将显着增加未来对诊断影像的需求。这一趋势是由多种因素推动的，这些因素强调了尖端技术在增强医疗诊断和患者护理方面的关键作用。这项需求的关键驱动因素之一是人工智慧 (AI) 和机器学习演算法的持续开发和整合到诊断成像流程中。这些人工智慧驱动的系统有潜力加快并提高影像分析的准确性，帮助医疗保健专业人员进行早期疾病检测、诊断和治疗计划。人工智慧可以帮助识别医学影像中的微妙模式或异常，使诊断过程更有效率和有效。

此外，3D 和 4D 影像技术（例如 3D 乳房 X 光摄影和 4D 胎儿超音波）的出现彻底改变了诊断影像领域。这些技术提供了解剖结构和生理过程的更详细和动态的视图，为临床医生的诊断和治疗提供了宝贵的见解。随着这些先进成像方式变得更容易获得和负担得起，对它们的需求预计会增加。诊断成像领域越来越多地采用先进技术，有望透过提高诊断准确性、可及性和便利性来彻底改变该领域。随着这些技术变得更加广泛并融入医疗保健系统，对诊断成像的需求预计将会上升，最终导致未来患者护理和结果的改善。

老年人口的增加

老年人口的增加预计将显着增加未来对诊断影像的需求。这种人口结构变化是由预期寿命延长和出生率下降所推动的，导致全球老年人口不断增加。老化过程带来了各种慢性疾病和与年龄相关的疾病的可能性更高，这需要增加诊断影像服务。

随着个体年龄的增长，心血管疾病、癌症、骨关节炎和神经系统疾病等慢性疾病的风险也会增加。诊断影像在这些疾病的早期检测、疾病监测和治疗计划中发挥着至关重要的作用。定期筛检和影像学检查对于有效管理老年族群的健康至关重要。老年人经常患有复杂的医疗状况，需要采用多学科方法进行诊断和治疗。 MRI、CT 扫描和 PET 扫描等先进影像技术可提供对这些疾病的详细、全面的了解，帮助医疗保健提供者做出准确的诊断并针对个别患者制定治疗方案。

不断增长的老年人口是未来诊断影像需求增加的重要驱动力。随着老年人口不断扩大，医疗保健系统必须做好准备，以满足对先进影像服务不断增长的需求，以促进早期诊断、提高治疗效果并提高老年人的整体护理品质。

引进技术先进的系统

由于对慢性病早期和具有成本效益的诊断的需求不断增加以及全球人口老化等因素，对诊断影像设备的需求预计将显着增长。影响市场成长的两个关键驱动因素是技术先进设备的引进和亚洲国家医疗保健产业的扩张。例如，富士软片公司于2020年5月推出了一种新的基于人工智慧（AI）的肺结节检测技术。该技术透过检测胸部CT扫描中的肺结节来帮助诊断肺癌。

此外，2020年11月，佳能医疗系统公司推出了单次心跳光谱心臟CT，可在一次心跳中捕捉整个心臟的光谱影像。该技术结合了快速 kVp 切换和深度学习光谱重建。各种创新产品的推出预计将推动需求并促进市场的成长。

主要市场挑战

昂贵的程序和设备

与昂贵的程序和设备相关的成本阻碍了对诊断影像的需求，这给医疗保健系统、提供者和患者带来了重大挑战。取得和维护先进影像设备（例如 MRI 机器、CT 扫描仪和 PET 扫描仪）的高昂成本给医疗机构带来了相当大的财务负担。这些机构经常透过增加影像服务费用将这些成本转嫁给患者，使没有足够保险或经济能力的个人更难获得这些服务。某些影像程序的复杂性需要对技术人员和放射科医生进行专门培训，这会增加劳动成本。一些地区合格人员的稀缺性进一步加剧了这个问题，导致影像预约的等待时间更长并导致诊断延迟。

与诊断影像程序和设备相关的高成本阻碍了他们的需求，可能限制许多患者获得重要的医疗诊断。应对这项挑战需要创新方法，例如公私合作伙伴关係、研究具有成本效益的影像技术以及改善保险覆盖范围，以确保患者能够获得所需的诊断影像服务，而不会陷入过度的经济困难。这对于及时准确的诊断以及医疗保健结果的整体改善至关重要。

维护和升级成像设备的经常性费用

另一个因素是维护和升级影像设备以确保其准确性并符合不断发展的医疗保健标准的经常性成本。诊断影像设备，例如 MRI 机器、CT 扫描仪和超音波设备，需要定期维护以确保其正常功能和准确性。日常维护、校准和维修对于保持影像品质和可靠性是必要的。维护一系列复杂的影像设备的成本可能很高，会耗尽医疗机构的财务资源。

这些持续的成本可能会使医疗机构犹豫是否要投资新的影像技术，并可能限制某些地区或设施获得最先进的影像服务。维护和升级成像设备的经常性成本所带来的财务限制可能会导致多种不利后果，包括成像预约的等待时间更长、获得尖端诊断技术的机会有限，以及医疗保健提供者寻求收回成本时可能会增加病人的成本他们的开支。

主要市场趋势

护理点成像

更小型、便携式和床边成像设备的发展使得在紧急情况、救护车和偏远地区更容易进行诊断成像，从而减少了对集中成像设施的需求。在紧急情况下，例如创伤病例或中风事件，及时诊断对于患者的治疗结果至关重要。便携式影像设备使医疗专业人员能够在现场快速评估受伤、内出血或神经系统状况，从而促进有关治疗方案的快速决策。救护车配备便携式影像设备，使护理人员和紧急医疗人员能够在前往医院的途中进行初步扫描和诊断。这些即时资讯可以帮助医院为即将到来的患者做好准备，并在患者抵达后采取适当的干预措施。

在无法获得集中医疗设施的偏远或服务不足的地区，便携式影像设备可以为患者所在位置提供诊断功能。这对于否则在接受及时和全面的医疗服务方面将面临挑战的社区尤其重要。

先进的成像方式

正子断层扫描 (PET)-MRI 和混合成像技术等影像方法的不断进步，为改进诊断提供了更全面、更详细的资讯。 PET-MRI 将 PET 扫描的功能和代谢资讯与 MRI 扫描的详细解剖资讯结合。这种同步成像在一次扫描中提供了身体结构和功能的整体视图，从而可以进行更准确和全面的评估。传统的 PET-CT 扫描区分不同软组织的能力有限。另一方面，PET-MRI 在软组织对比方面表现出色，可以检测大脑、肝臟和前列腺等器官的细微异常，这使其在肿瘤学和神经学方面具有无价的价值。

与 PET-CT 相比，PET-MRI 减少了辐射暴露，这对于儿科患者和需要多次扫描的个人特别有利。较低的辐射剂量还可以最大限度地减少与辐射暴露相关的潜在长期风险。

细分市场洞察

产品类型见解

根据产品类型，市场分为 X 光成像系统、电脑断层扫描 (CT) 扫描仪、超音波成像系统、磁振造影 (MRI) 系统和核子成像系统。 X 光成像系统因其低成本且能够产生准确的影像而引领诊断成像市场，从而提供肌肉骨骼系统的清晰概念。这对于诊断骨折、骨骼疾病和关节异常特别有益。

对行动 X 光系统不断增长的需求进一步支持了 X 光成像系统领域的成长，行动 X 光系统可以在各种医疗保健环境中方便地进行成像。此外，医院和诊断中心数量的不断增加，特别是在新兴国家，也促进了这个市场的成长。数位技术的进步也提高了 X 光成像的品质和效率，使其成为许多医疗保健专业人员的首选。推动 X 光成像系统发展的另一个因素是该过程的无痛性和非侵入性。患者发现 X 光检查相对舒适且快捷，从而提高了患者满意度。此外，与 MRI 和 CT 扫描仪等其他方式相比，X 光通常更便宜，这使得预算有限的医疗机构更容易使用它们。总体而言，X 光技术的持续进步，加上其成本效益和诊断准​​确性，有助于 X 光成像系统在诊断成像市场中占据主导地位。

最终使用者见解

根据最终用户，市场分为医院、诊断影像中心和门诊影像中心。目前，医院所占比例最大。然而，在预测期内，诊断中心对影像系统的采用预计将以最高的年复合成长率(CAGR) 成长。这可以归因于几个因素，包括由于诊断成像程序的需求不断增长而推动私人成像中心数量的增加。这个最终用户细分市场的成长预计将受到准确和及时诊断的需求以及成像技术进步的推动，从而实现更好的可视化和改善患者的治疗结果。随着人们越来越关注疾病的早期发现和预防，诊断影像中心在提供高品质医疗保健服务方面的作用变得越来越重要。

区域洞察

2022年，北美成为医疗/诊断影像市场的主导者，占据了主要份额。凭藉完善的医疗保健基础设施和医疗成像外包主要参与者的存在，该地区预计将在预测期内保持其在全球医疗成像市场的主导地位。这可以归因于慢性病的盛行率不断增加，从而导致对先进诊断影像技术的需求不断增长。

另一方面，预计2024年至2028年亚太地区将呈现最高的年复合成长率（CAGR）。这可归因于多种因素，包括医院数量的快速增加、早期诊断需求的不断增长，以及癌症和心臟病等疾病的日益普及。此外，该地区老年人口数量大幅增加，进一步推动了对医学影像服务的需求。总体而言，这些趋势显示医学影像市场充满活力且不断发展，北美将保持其据点，而亚太地区将成为未来几年的关键成长区域。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球诊断影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型（X 光、超音波、电脑断层扫描、核子造影和磁振造影）
    • 按应用（肿瘤科、神经科、心臟科、妇科、骨科等）
    • 按最终用户（医院、诊断影像中心和门诊影像中心）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美诊断影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲诊断影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区诊断影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲诊断影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲诊断影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非诊断影像
    • 沙乌地阿拉伯诊断成像
    • 阿联酋诊断成像

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球诊断影像市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • GE Healthcare Inc.
    • Philips Healthcare Informatics Inc.
    • Hitachi Medical Corporation
    • Hologic, Inc.
    • Siemens Healthcare GmbH
    • Samsung Medison
    • Shimadzu Corporation
    • Toshiba Medical Systems Corporation
    • Esaote SPA
    • Fujifilm Corporation

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 4950

In 2022, the Global Diagnostic Imaging Market reached a valuation of USD 25.09 billion, and it is poised for remarkable growth in the forecast period with a projected Compound Annual Growth Rate (CAGR) of 5.53% through 2028.

Diagnostic imaging comprises a diverse array of techniques utilized to visualize the human body, serving as a vital tool in the diagnosis, monitoring, and treatment of medical conditions. Each imaging modality offers distinct insights into the targeted body part, including the detection of diseases, injuries, or the assessment of the effectiveness of medical interventions. These non-invasive methods for capturing internal body structures, collectively referred to as diagnostic imaging, encompass technologies such as X-rays, magnetic resonance imaging (MRI), computed tomography (CT), prenatal diagnostics, and other specialized modalities.

Healthcare professionals harness the power of diagnostic imaging to establish precise diagnoses and conduct comprehensive patient assessments. Moreover, this technology plays a crucial role in closely monitoring a patient's response to treatment regimens and medications. Diagnostic imaging encompasses a wide range of procedures, enabling healthcare providers to gain valuable visual insights into the body's internal structures, ultimately aiding in the accurate identification of the root causes of health issues or injuries.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 25.09 Billion
Market Size 2028USD 34.90 Billion
CAGR 2023-20285.53%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

Rise in the Prevalence of Chronic Diseases

The rise in the prevalence of chronic diseases is expected to significantly increase the demand for diagnostic imaging in the future. This upward trend is driven by several interconnected factors that underscore the critical role of imaging technologies in the diagnosis and management of chronic health conditions.

Chronic diseases, such as cardiovascular disease, cancer, diabetes, and respiratory disorders, are becoming increasingly common worldwide due to factors like aging populations, sedentary lifestyles, and dietary habits. These conditions often require precise and early diagnosis to initiate effective treatments and improve patient outcomes. Diagnostic imaging techniques like X-rays, CT scans, MRIs, and ultrasound play a pivotal role in detecting and monitoring these diseases, allowing healthcare providers to make informed decisions about patient care. Diagnostic imaging helps tailor treatment plans to individual patient needs, allowing for more effective and less invasive interventions. For example, cancer imaging techniques help oncologists precisely locate tumors, assess their stage, and monitor treatment response, all of which contribute to better treatment outcomes.

Increased Adoption of Advanced Technologies in Diagnostic imaging

The increased adoption of advanced technologies in diagnostic imaging is poised to significantly boost the demand for diagnostic imaging in the future. This trend is driven by a convergence of factors that underscore the pivotal role of cutting-edge technologies in enhancing healthcare diagnostics and patient care. One of the key drivers of this demand is the continuous development and integration of artificial intelligence (AI) and machine learning algorithms into diagnostic imaging processes. These AI-driven systems have the potential to expedite and improve the accuracy of image analysis, aiding healthcare professionals in early disease detection, diagnosis, and treatment planning. AI can assist in identifying subtle patterns or abnormalities in medical images, making the diagnostic process more efficient and effective.

Furthermore, the advent of 3D and 4D imaging techniques, such as 3D mammography and 4D fetal ultrasound, has revolutionized the field of diagnostic imaging. These technologies provide more detailed and dynamic views of anatomical structures and physiological processes, offering clinicians invaluable insights for diagnosis and treatment. The demand for these advanced imaging modalities is expected to increase as they become more accessible and affordable. The increased adoption of advanced technologies in diagnostic imaging promises to revolutionize the field by enhancing diagnostic accuracy, accessibility, and convenience. As these technologies become more widespread and integrated into healthcare systems, the demand for diagnostic imaging is expected to rise, ultimately leading to improved patient care and outcomes in the future.

Increase in the Geriatric Population

The increase in the geriatric population is expected to significantly drive up the demand for diagnostic imaging in the future. This demographic shift is driven by longer life expectancies and declining birth rates, resulting in a growing elderly population worldwide. The aging process brings with it a higher likelihood of developing various chronic diseases and age-related conditions, which necessitate increased diagnostic imaging services.

As individuals age, their risk of developing chronic illnesses such as cardiovascular disease, cancer, osteoarthritis, and neurological disorders rises. Diagnostic imaging plays a crucial role in early detection, disease monitoring, and treatment planning for these conditions. Regular screenings and imaging tests are essential for managing the health of the elderly population effectively. Older adults often present with complex medical conditions that require a multidisciplinary approach to diagnosis and treatment. Advanced imaging technologies like MRI, CT scans, and PET scans provide detailed and comprehensive insights into these conditions, aiding healthcare providers in making accurate diagnoses and tailoring treatments to individual patients.

The growing geriatric population is a significant driver of increased demand for diagnostic imaging in the future. As the elderly population continues to expand, healthcare systems must be prepared to meet the rising need for advanced imaging services to facilitate early diagnosis, enhance treatment outcomes, and improve the overall quality of care for older adults.

Introduction of Technologically Advanced Systems

The demand for diagnostic imaging equipment is projected to experience significant growth due to factors such as the increasing need for early and cost-effective diagnoses of chronic diseases and the aging global population. Two key drivers influencing market growth are the introduction of technologically advanced devices and the expansion of the healthcare industry in Asian countries. For example, Fujifilm Corporation introduced a new Artificial Intelligence (AI)-based lung nodule detection technology in May 2020. This technology aids in the diagnosis of lung cancer by detecting pulmonary nodules in chest CT scans.

Furthermore, in November 2020, Canon Medical Systems Corporation introduced the One-Beat Spectral Cardiac CT, which enables the capture of whole-heart spectral images in a single heartbeat. This technology incorporates quick kVp switching and deep learning spectral reconstruction. The introduction of various innovative products is expected to drive demand and contribute to the market's growth.

Key Market Challenges

Expensive Procedures and Equipment

The demand for diagnostic imaging is being hindered by the cost associated with expensive procedures and equipment, posing significant challenges for healthcare systems, providers, and patients alike. The high cost of acquiring and maintaining advanced imaging equipment, such as MRI machines, CT scanners, and PET scanners, places a considerable financial burden on healthcare institutions. These institutions often pass these costs onto patients through increased charges for imaging services, making them less accessible for individuals without adequate insurance coverage or financial means. The complexity of certain imaging procedures necessitates specialized training for technicians and radiologists, which can increase labor costs. The scarcity of qualified personnel in some regions further exacerbates this issue, leading to longer wait times for imaging appointments and delayed diagnoses.

The high costs associated with diagnostic imaging procedures and equipment are hindering their demand, potentially limiting access to crucial medical diagnostics for many patients. Addressing this challenge requires innovative approaches, such as public-private partnerships, research into cost-effective imaging technologies, and improved insurance coverage, to ensure that patients can access the diagnostic imaging services they need without undue financial hardship. This is essential for both timely and accurate diagnoses and the overall improvement of healthcare outcomes.

Recurring Expense of Maintaining and Upgrading Imaging Equipment

Another factor is the recurring expense of maintaining and upgrading imaging equipment to ensure its accuracy and compliance with evolving healthcare standards. Diagnostic imaging equipment, such as MRI machines, CT scanners, and ultrasound devices, require regular maintenance to ensure their proper functionality and accuracy. Routine servicing, calibration, and repairs are necessary to maintain image quality and reliability. The cost of maintaining a fleet of sophisticated imaging devices can be substantial, draining financial resources from healthcare facilities.

These ongoing costs can make healthcare institutions hesitant to invest in new imaging technologies and may limit the accessibility of state-of-the-art imaging services to certain regions or facilities. The financial constraints imposed by the recurring costs of maintaining and upgrading imaging equipment can lead to several adverse consequences, including longer waiting times for imaging appointments, limited access to cutting-edge diagnostic technologies, and potentially higher costs for patients as healthcare providers seek to recoup their expenses.

Key Market Trends

Point-of-Care Imaging

The development of smaller, portable, and point-of-care imaging devices is making diagnostic imaging more accessible in emergency situations, ambulances, and remote areas, reducing the need for centralized imaging facilities. In emergency situations, such as trauma cases or stroke incidents, timely diagnosis is critical for patient outcomes. Portable imaging devices allow medical professionals to quickly assess injuries, internal bleeding, or neurological conditions on-site, facilitating rapid decision-making regarding treatment options. Equipping ambulances with portable imaging devices enables paramedics and emergency medical personnel to perform preliminary scans and diagnostics while en route to the hospital. This real-time information can help hospitals prepare for incoming patients and initiate appropriate interventions upon arrival.

In remote or underserved areas with limited access to centralized healthcare facilities, portable imaging devices bring diagnostic capabilities to the patient's location. This is particularly important for communities that would otherwise face challenges in receiving timely and comprehensive medical care.

Advanced Imaging Modalities

Continuous advancements in imaging modalities, such as positron emission tomography (PET)-MRI and hybrid imaging technologies, offer more comprehensive and detailed information for improved diagnosis. PET-MRI combines the functional and metabolic information from PET scans with the detailed anatomical information from MRI scans. This simultaneous imaging provides a holistic view of the body's structures and functions in a single scan, allowing for more accurate and comprehensive assessments. Traditional PET-CT scans are limited in their ability to distinguish between different soft tissues. PET-MRI, on the other hand, excels in soft tissue contrast and can detect subtle abnormalities in organs like the brain, liver, and prostate, making it invaluable in oncology and neurology.

PET-MRI reduces radiation exposure compared to PET-CT, making it particularly advantageous for pediatric patients and individuals requiring multiple scans over time. The lower radiation dose also minimizes potential long-term risks associated with radiation exposure.

Segmental Insights

Product Type Insights

Based on the product type, the market is segmented into X-ray imaging systems, computed tomography (CT) scanners, ultrasound imaging systems, magnetic resonance imaging (MRI) systems, and nuclear imaging systems. X-ray imaging systems lead the diagnostic imaging market owing to their low cost and the ability to produce accurate images that provide a clear idea of the musculoskeletal system. This is particularly beneficial for diagnosing fractures, bone diseases, and joint abnormalities.

The growth of the X-ray imaging systems segment is further supported by the increasing demand for mobile X-ray systems, which allow for convenient imaging in various healthcare settings. Additionally, the expanding number of hospitals and diagnostic centres, especially in emerging countries, contributes to the growth of this market segment. The advancements in digital technology have also improved the quality and efficiency of X-ray imaging, making it a preferred choice for many healthcare professionals. Another factor driving the growth of X-ray imaging systems is the painless and non-invasive nature of the procedures. Patients find X-ray examinations relatively comfortable and quick, which leads to improved patient satisfaction. Moreover, X-rays are generally more affordable compared to other modalities such as MRI and CT scanners, making them more accessible for healthcare facilities with budget constraints. Overall, the continued advancements in X-ray technology, coupled with its cost-effectiveness and diagnostic accuracy, contribute to the dominance of X-ray imaging systems in the diagnostic imaging market.

End User Insights

Based on the end user, the market is segmented into hospitals, diagnostic imaging centers, and Ambulatory Imaging Centres. Currently, hospitals comprise the largest share. However, the adoption of imaging systems by diagnostic centers is expected to grow at the highest compound annual growth rate (CAGR) during the forecast period. This can be attributed to several factors, including the increasing number of private imaging centers fueled by the rising demand for diagnostic imaging procedures. The growth of this end user segment is expected to be driven by the need for accurate and timely diagnosis, as well as the advancements in imaging technology that enable better visualization and improved patient outcomes. With the increasing focus on early detection and prevention of diseases, the role of diagnostic imaging centers in delivering high-quality healthcare services is becoming increasingly important.

Regional Insights

In 2022, North America emerged as the dominant player in the medical/diagnostic imaging market, capturing a major share. With a well-established healthcare infrastructure and the presence of key players for medical imaging outsourcing, the region is poised to maintain its dominance in the global medical imaging market during the forecast period. This can be attributed to the increasing prevalence of chronic diseases, which has led to a growing demand for advanced diagnostic imaging technologies.

On the other hand, Asia-Pacific is projected to exhibit the highest compound annual growth rate (CAGR) from 2024 to 2028. This can be attributed to several factors, including the rapid increase in the number of hospitals, the rising demand for early diagnosis, and the growing prevalence of diseases such as cancer and cardiac ailments. Additionally, the region is experiencing a significant upsurge in the number of geriatric populations, further driving the demand for medical imaging services. Overall, these trends indicate a dynamic and evolving medical imaging market, with North America maintaining its stronghold and Asia-Pacific emerging as a key growth region in the coming years.

Key Market Players

  • GE Healthcare Inc.
  • Philips Healthcare Informatics Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Siemens Healthcare GmbH
  • Samsung Medison
  • Shimadzu Corporation
  • Toshiba Medical Systems Corporation
  • Esaote S.P.A
  • Fujifilm Corporation

Report Scope:

In this report, the Global Diagnostic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Imaging Market, By Product Type:

  • X-Ray
  • Ultrasound
  • Computed Tomography
  • Nuclear Imaging
  • Magnetic Resonance Imaging

Diagnostic Imaging Market, By Application:

  • Oncology
  • Neurology
  • Cardiology
  • Gynaecology
  • Orthopaedics
  • Others

Diagnostic Imaging Market, By End User:

  • Hospitals
  • Diagnostic Imaging Centres
  • Ambulatory Imaging Centres

Diagnostic Imaging Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Market.

Available Customizations:

  • Global Diagnostic Imaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (X-Ray, Ultrasound, Computed Tomography, Nuclear Imaging, and Magnetic Resonance Imaging)
    • 5.2.2. By Application (Oncology, Neurology, Cardiology, Gynaecology, Orthopaedics, and Others)
    • 5.2.3. By End User (Hospitals, Diagnostic Imaging Centres, and Ambulatory Imaging Centres)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Diagnostic Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diagnostic Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Diagnostic Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Diagnostic Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Diagnostic Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diagnostic Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Diagnostic Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Diagnostic Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Diagnostic Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Diagnostic Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Diagnostic Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diagnostic Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Diagnostic Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Diagnostic Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Diagnostic Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Diagnostic Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Diagnostic Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diagnostic Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Diagnostic Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Diagnostic Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Diagnostic Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diagnostic Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Diagnostic Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Diagnostic Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Diagnostic Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. GE Healthcare Inc.
    • 15.5.2. Philips Healthcare Informatics Inc.
    • 15.5.3. Hitachi Medical Corporation
    • 15.5.4. Hologic, Inc.
    • 15.5.5. Siemens Healthcare GmbH
    • 15.5.6. Samsung Medison
    • 15.5.7. Shimadzu Corporation
    • 15.5.8. Toshiba Medical Systems Corporation
    • 15.5.9. Esaote S.P.A
    • 15.5.10. Fujifilm Corporation

16. Strategic Recommendations

17. About Us & Disclaimer